Specific Noncovalent Interactions Determine Optimal Structure of a Buried Ligand Moiety: QM/MM and Pure QM Modeling of Complexes of the Small-Molecule CD4 Mimetics and HIV-1 gp120

被引:4
作者
Moraca, Francesca [1 ]
Rinaldo, David [2 ]
Smith, Amos B., III [3 ]
Abrams, Cameron F. [4 ]
机构
[1] Schrodinger Inc, 222 Third St, Cambridge, MA 02142 USA
[2] Schrodinger GmbH, Dynamostr 13, D-68165 Mannheim, Germany
[3] Univ Penn, Dept Chem, 231 S 34th St, Philadelphia, PA 19104 USA
[4] Drexel Univ, Dept Chem & Biol Engn, 3141 Chestnut St, Philadelphia, PA 19104 USA
基金
美国国家科学基金会;
关键词
gp120; inhibitors; HIV-1; QM; MM; small-molecule CD4 mimetics; STRUCTURE-BASED DESIGN; ENTRY INHIBITORS; HYDROPHOBIC ENCLOSURE; ENVELOPE GLYCOPROTEIN; ACCURATE DOCKING; X-RAY; PROTEIN; BINDING; OPTIMIZATION; MIMICS;
D O I
10.1002/cmdc.201700728
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The small-molecule CD4 mimetics (smCD4mcs) are a class of highly potent HIV-1 entry inhibitors characterized by a unique structure-activity relationship (SAR). They share a halogenated phenyl ring (region1) that deeply inserts into an otherwise water-filled cavity at the CD4 binding site on the gp120 surface, the so-called F43 cavity. Conservative modifications to region1 away from this halogenated phenyl motif have all led to loss of activity, despite the fact that they are predicted by standard empirical computational approaches to bind equally well, making it difficult to further optimize this region of the compounds to increase binding to gp120. In this study we used quantum mechanical methods to understand the roots of the interactions between region1 and the F43 cavity. We clearly demonstrate the presence of halogen bond/sigma-hole and dispersion interactions between region1 and the F43 cavity residues F376-N377, which are not captured by standard molecular mechanics approaches and the role played by the smCD4mc in the F43 cavity desolvation. These findings rationalize why the halogenated region1 has proven so difficult to move beyond in smCD4mc optimization, in agreement with experimental evidence.
引用
收藏
页码:627 / 633
页数:7
相关论文
共 4 条
  • [1] Computational Evaluation of HIV-1 gp120 Conformations of Soluble Trimeric gp140 Structures as Targets for de Novo Docking of First- and Second-Generation Small-Molecule CD4 Mimics
    Moraca, Francesca
    Acharya, Kriti
    Melillo, Bruno
    Smith, Amos B., III
    Chaiken, Irwin
    Abrams, Cameron F.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (10) : 2069 - 2079
  • [2] Identification of gp120 Residue His105 as a Novel Target for HIV-1 Neutralization by Small-Molecule CD4-Mimics
    Fritschi, Christopher J.
    Liang, Shuaiyi
    Mohammadi, Mohammadjavad
    Anang, Saumya
    Moraca, Francesca
    Chen, Junhua
    Madani, Navid
    Sodroski, Joseph G.
    Abrams, Cameron F.
    Hendrickson, Wayne A.
    Smith, Amos B., III
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (11): : 1824 - 1831
  • [3] Rational conversion of noncontinuous active region in proteins into a small orally bioavailable macrocyclic drug-like molecule: The HIV-1 CD4:gp120 paradigm
    Hurevich, Mattan
    Swed, Avi
    Joubran, Salim
    Cohen, Shira
    Freeman, Noam S.
    Britan-Rosich, Elena
    Briant-Longuet, Laurence
    Bardy, Martine
    Devaux, Christian
    Kotler, Moshe
    Hoffman, Amnon
    Gilon, Chaim
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (15) : 5754 - 5761
  • [4] A New Family of Small-Molecule CD4-Mimetic Compounds Contacts Highly Conserved Aspartic Acid 368 of HIV-1 gp120 and Mediates Antibody-Dependent Cellular Cytotoxicity
    Ding, Shilei
    Grenier, Melissa C.
    Tolbert, William D.
    Vezina, Dani
    Sherburn, Rebekah
    Richard, Jonathan
    Prevost, Jeremie
    Chapleau, Jean-Philippe
    Gendron-Lepage, Gabrielle
    Medjahed, Halima
    Abrams, Cameron
    Sodroski, Joseph
    Pazgier, Marzena
    Smith, Amos B., III
    Finzi, Andres
    JOURNAL OF VIROLOGY, 2019, 93 (24)